157 related articles for article (PubMed ID: 9794111)
1. Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction.
Pieper GM; Dembny K; Siebeneich W
Diabetologia; 1998 Oct; 41(10):1220-6. PubMed ID: 9794111
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction.
Pieper GM; Siebeneich W; Roza AM; Jordan M; Adams MB
J Cardiovasc Pharmacol; 1996 Dec; 28(6):741-5. PubMed ID: 8961070
[TBL] [Abstract][Full Text] [Related]
3. Syngeneic pancreatic islet transplantation reverses endothelial dysfunction in experimental diabetes.
Pieper GM; Jordan M; Adams MB; Roza AM
Diabetes; 1995 Sep; 44(9):1106-13. PubMed ID: 7657036
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with the 21-aminosteroid U74389F, an inhibitor of lipid peroxidation, does not prevent diabetic endothelial dysfunction.
Pieper GM; Jordan M; Roza AM
Cardiovasc Drugs Ther; 1997 Jul; 11(3):435-40. PubMed ID: 9310271
[TBL] [Abstract][Full Text] [Related]
5. Vascular protective actions of a nitric oxide aspirin analog in both in vitro and in vivo models of diabetes mellitus.
Pieper GM; Siebeneich W; Olds CL; Felix CC; Del Soldato P
Free Radic Biol Med; 2002 Jun; 32(11):1143-56. PubMed ID: 12031899
[TBL] [Abstract][Full Text] [Related]
6. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin.
Pieper GM
J Cardiovasc Pharmacol; 1997 Jan; 29(1):8-15. PubMed ID: 9007664
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic transplantation reverses endothelial dysfunction in experimental diabetes mellitus.
Pieper GM; Adams MB; Roza AM
Surgery; 1998 Jan; 123(1):89-95. PubMed ID: 9457228
[TBL] [Abstract][Full Text] [Related]
8. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta.
Keegan A; Walbank H; Cotter MA; Cameron NE
Diabetologia; 1995 Dec; 38(12):1475-8. PubMed ID: 8786022
[TBL] [Abstract][Full Text] [Related]
9. Chronic or delayed treatment with an oral dithiocarbamate analog decreases glycation and protects diabetic arteries.
Pieper GM; Siebeneich W; Olds CL; Lai CS
Eur J Pharmacol; 2003 Jul; 472(1-2):127-34. PubMed ID: 12860481
[TBL] [Abstract][Full Text] [Related]
10. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals.
Pieper GM; Langenstroer P; Siebeneich W
Cardiovasc Res; 1997 Apr; 34(1):145-56. PubMed ID: 9217884
[TBL] [Abstract][Full Text] [Related]
11. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration.
Pieper GM
Diabetologia; 1999 Feb; 42(2):204-13. PubMed ID: 10064101
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction.
Pieper GM; Siebeneich W
J Cardiovasc Pharmacol; 1998 Jul; 32(1):101-5. PubMed ID: 9676728
[TBL] [Abstract][Full Text] [Related]
13. Impaired relaxation in aorta from streptozotocin-diabetic rats: effect of aminoguanidine (AMNG) treatment.
Ozyazgan S; Unlucerci Y; Bekpinar S; Akkan AG
Int J Exp Diabetes Res; 2000; 1(2):145-53. PubMed ID: 11469398
[TBL] [Abstract][Full Text] [Related]
14. Biological evaluation of the nitric oxide-trapping agent, N-methyl-D-glucamine dithiocarbamate-Fe2+, as a probe of nitric oxide activity released from control and diabetic rat endothelium.
Pieper GM; Lai CS
Jpn J Pharmacol; 1999 Aug; 80(4):359-70. PubMed ID: 10496337
[TBL] [Abstract][Full Text] [Related]
15. Lack of endothelium-derived hyperpolarizing factor (EDHF) up-regulation in endothelial dysfunction in aorta in diabetic rats.
Csanyi G; Lepran I; Flesch T; Telegdy G; Szabo G; Mezei Z
Pharmacol Rep; 2007; 59(4):447-55. PubMed ID: 17901574
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity.
Lu CW; Lin Y; Lei YP; Wang L; He ZM; Xiong Y
PLoS One; 2017; 12(7):e0179908. PubMed ID: 28715444
[TBL] [Abstract][Full Text] [Related]
17. Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats.
Rodríguez-Mañas L; Angulo J; Peiró C; Llergo JL; Sánchez-Ferrer A; López-Dóriga P; Sánchez-Ferrer CF
Br J Pharmacol; 1998 Apr; 123(8):1495-502. PubMed ID: 9605553
[TBL] [Abstract][Full Text] [Related]
18. Impairment of nitric oxide-mediated relaxations in anaesthetized autoperfused streptozotocin-induced diabetic rats.
Angulo J; Rodríguez-Mañas L; Peiró C; Neira M; Marín J; Sánchez-Ferrer CF
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):529-37. PubMed ID: 9840421
[TBL] [Abstract][Full Text] [Related]
19. Increased nitric oxide activity compensates for increased oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes.
Joshi A; Woodman OL
Naunyn Schmiedebergs Arch Pharmacol; 2012 Nov; 385(11):1083-94. PubMed ID: 22965470
[TBL] [Abstract][Full Text] [Related]
20. Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature.
Rodríguez-Mañas L; Angulo J; Vallejo S; Peiró C; Sánchez-Ferrer A; Cercas E; López-Dóriga P; Sánchez-Ferrer CF
Diabetologia; 2003 Apr; 46(4):556-66. PubMed ID: 12739028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
